Clinical Trials Logo

Filter by:
NCT ID: NCT00276042 Completed - Otitis Media Clinical Trials

A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media

Start date: January 2006
Phase: Phase 2
Study type: Interventional

The study will be conducted in infants and children with acute otitis media, 6 months to less than 7 years old, in Costa Rica and Israel. The primary objective of this trial will be to describe bacteriologic efficacy in those with initial culture positive specimens with different dosages of faropenem

NCT ID: NCT00275418 Recruiting - Crohn's Disease Clinical Trials

Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease

Start date: July 2002
Phase: Phase 3
Study type: Interventional

Many inflammatory disorders in the body are linked to oxidative tissue damage. Anti-oxidants that are present in many natural food sources may provide protection from such damage. Beta carotene is an anti-oxidant vitamin present in many fruits and vegetables. The algae Dunaliella is particularly rich in beta carotene. In this prospective trial we want to investigate whether beta carotene from Dunaliella may prevent exacerbations of Crohn's disease.

NCT ID: NCT00275210 Completed - Colonic Neoplasms Clinical Trials

MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

Start date: October 1998
Phase: Phase 3
Study type: Interventional

To evaluate the FOLFOX regimen versus LV5FU2 in the adjuvant treatment of stage II and III colon cancer. Primary objective: Disease Free Survival (DFS) Secondary objective: Overall Survival (OS), safety (including long term toxicity)

NCT ID: NCT00274690 Completed - Clinical trials for Postoperative Nausea and Vomiting

Post-Operative Nausea And Vomiting Study In Female Patients

Start date: February 2005
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.

NCT ID: NCT00274651 Terminated - Clinical trials for Non-Hodgkin's Lymphoma

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

PXD101-CLN-6
Start date: January 2006
Phase: Phase 2
Study type: Interventional

Open-label, non-randomized trial to assess the effectiveness of PXD101 in patients with recurrent or refractory cutaneous or peripheral and other types of T-cell lymphomas. PXD101 is a new, potent histone deacetylase (HDAC) inhibitor. Patients are treated with belinostat(PXD101) 1000 mg/m2 on days 1-5 of a 21 day cycle.

NCT ID: NCT00274365 Completed - Clinical trials for Remote Consultation [L01.178.847.652.550]

Consultations in Psychiatry Through Videoconference

Start date: November 2005
Phase: N/A
Study type: Interventional

Online consulatations through videoconference in the field of psychiatry given to general practitioners will reduce costs of medical treatment and improve service.

NCT ID: NCT00274326 Completed - Clinical trials for Congestive Heart Failure

DILIPO (DILutIonal HyPOnatremia)

Start date: May 2005
Phase: Phase 3
Study type: Interventional

Primary: - To assess the efficacy of SR121463B in correcting hyponatremia in patients with dilutional hyponatremia other than SIADH or cirrhosis Secondary: - To assess the long-term efficacy of SR121463B in maintaining normonatremia in these patients - To assess the safety and tolerability of SR121463B

NCT ID: NCT00274196 Recruiting - Occult Fractures Clinical Trials

Ultrasound as a Diagnostic Tool for Occult Hip Fractures

Start date: February 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to measure the sensitivity and specificity of ultrasound exam of the hip in diagnosing occult hip fractures.

NCT ID: NCT00273949 Active, not recruiting - Clinical trials for Nosocomial Infection

Lactulose for the Prevention of Nosocomial Infections in Children

Start date: January 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the ability of lactulose, a prebiotic agent, to prevent hospital acquired infection in children

NCT ID: NCT00273572 Completed - Diabetes Clinical Trials

Lifestyle Intervention in Obese Arab Women

Start date: December 2004
Phase: N/A
Study type: Interventional

The study protocol aims to test the hypothesis that a lifestyle intervention program aimed to increase leisure-time physical activity and reduce body weight will improve the parameters of the metabolic syndrome and quality of life among obese, non-diabetic Arab women